Real-world effectiveness and safety of goserelin 10.8-mg depot in Chinese patients with localized or locally advanced prostate cancer.

Nanhui ChenZengjun WangMing ChenQi MaYi HeYujie WangXin LiMingxing QiuLei ShiShaoxing ZhuQun XieXiuheng LiuBenkang ShiGuowen LinWeizhong YangYongbin LiaoHaibin ZhangShusheng WangJiexian LiShaogang WangLijun DongHui ChenJiaju LuYongyi ChengXiaoping ZhangLulin MaLiqun ZhouHe WangShen LiDing-Wei Ye

Published in: Cancer biology & medicine (2024)

Goserelin 10.8-mg depot effectively achieved and maintained castration and was well-tolerated in Chinese patients with localized and locally advanced prostate cancer.

Keyphrases

locally advanced
prostate cancer
rectal cancer
neoadjuvant chemotherapy
radical prostatectomy
squamous cell carcinoma
radiation therapy
phase ii study
clinical trial